Reuters reveals drugmakers offer Canada C$1 billion to scrap some pending pricing rules


Reuters broke the news that the pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan. 1. The government has argued that Canada’s patented drug prices are too high, trailing only the United States and Switzerland, and that other countries with lower prices enjoy similar access to prescription medicines.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Equities

Regions: North America

Countries: Canada

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Major Global Story

Source link

What do you think?

Written by Chekmagazine


Leave a Reply

Your email address will not be published. Required fields are marked *



Reuters first to report China’s Ant considers Paytm stake sale amid tensions with India

FINAL LAPS: Chase Elliott holds the lead to win his first NASCAR Cup Series Championship